PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 61 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -76.1% | 15,000 | -76.9% | 0.01% | -76.2% |
| Q4 2020 | $218,000 | -21.9% | 65,000 | -18.2% | 0.04% | 0.0% |
| Q3 2020 | $279,000 | -21.2% | 79,470 | +3.2% | 0.04% | -40.8% |
| Q2 2020 | $354,000 | -0.6% | 76,970 | -28.5% | 0.07% | -52.0% |
| Q1 2020 | $356,000 | -38.2% | 107,577 | +14.0% | 0.15% | -7.5% |
| Q4 2019 | $576,000 | +10.8% | 94,351 | -24.4% | 0.16% | -42.9% |
| Q3 2019 | $520,000 | -52.2% | 124,788 | +50.5% | 0.28% | -79.5% |
| Q2 2019 | $1,088,000 | – | 82,931 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,643,704 | $27,704,000 | 2.29% |
| DAFNA Capital Management LLC | 360,542 | $1,503,000 | 0.56% |
| SABBY MANAGEMENT, LLC | 124,788 | $520,000 | 0.28% |
| Rock Springs Capital Management LP | 1,416,900 | $5,908,000 | 0.24% |
| Cormorant Asset Management, LP | 816,448 | $3,405,000 | 0.21% |
| SECTORAL ASSET MANAGEMENT INC | 196,000 | $817,000 | 0.14% |
| Leap Investments LP | 17,919 | $75,000 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 807,928 | $3,369,000 | 0.02% |
| Virtus ETF Advisers LLC | 21,738 | $91,000 | 0.02% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 20,000 | $83,000 | 0.01% |